Gewählte Publikation:
Keil, F; Kalhs, P; Haas, OA; Fritsch, G; Mitterbauer, G; Brugger, S; Lechner, K; Schwarzinger, I; Mannhalter, C; Linkesch, W; Kurz, M; Greinix, HT.
Graft failure after donor leucocyte infusion in relapsed chronic myeloid leukaemia: successful treatment with cyclophosphamide and antithymocyte globulin followed by peripheral blood stem cell infusion.
Br J Haematol. 1996; 94(1):120-122
Doi: 10.1046/j.1365-2141.1996.d01-1770.x
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Co-Autor*innen der Med Uni Graz
-
Greinix Hildegard
-
Linkesch Werner
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
We report a patient with chronic myeloid leukaemia who underwent allogeneic marrow transplantation (BMT) but had a molecular relapse 5 months and haematological relapse 15 months after BMT. Since therapy with alpha-interferon had been ineffective he received leucocyte infusions from his sibling donor. He developed acute graft-versus-host disease and became aplastic 6 weeks later. Despite donor marrow infusion and cytokine stimulation marrow aplasia persisted for 13 weeks. Then, donors' peripheral blood stem cells were given after conditioning with cyclophosphamide and antithymocyte globulin resulting in trilineage engraftment of donor haemopoiesis. Since then, the patient has been in continuous molecular remission for 11 months.
- Find related publications in this database (using NLM MeSH Indexing)
-
Antilymphocyte Serum - therapeutic use
-
Cyclophosphamide - therapeutic use
-
Fusion Proteins, bcr-abl - analysis
-
Graft Rejection -
-
Graft vs Host Disease - therapy
-
Humans -
-
Immunosuppressive Agents - therapeutic use
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - therapy
-
Leukocyte Transfusion -
-
Male -
-
Middle Aged -
-
Recurrence -
-
Stem Cell Transplantation -
-
Transplantation Chimera -
- Find related publications in this database (Keywords)
-
Ph(+) chronic myeloid leukaemia
-
donor leucocyte infusion induced aplasia
-
marrow graft failure